Rolf Ljung
51 – 60 of 259
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Increased inhibitor incidence in severe haemophilia A since 1990 attributable to more low titre inhibitors
van den Berg, H. Marijke ; Hashemi, S. Mojtaba ; Fischer, Kathelijn ; Petrini, Pia ; Ljung, Rolf LU
; Rafowicz, Anne
; Carcao, Manuel
; Auerswald, Günter
; Kurnik, Karin
and Kenet, Gili
, et al.
(2016)
In Thrombosis and Haemostasis
115(4).
p.729-737
- Contribution to journal › Article
-
Mark
Phenotype and genotype comparisons in carriers of haemophilia A
Olsson, A ; Ljung, R LU
; Hellgren, M
; Berntorp, E
LU
and Baghaei, F
(2016)
In Haemophilia
22(3).
p.235-237
- Contribution to journal › Article
-
Mark
Evaluating outcome of prophylaxis in haemophilia: objective and self-reported instruments should be combined.
Fischer, K ; Nijdam, A ; Holmström, M ; Petrini, P ; Ljung, Rolf LU
; van der Schouw, Y T
and Berntorp, E
(2016)
In Haemophilia
- Contribution to journal › Article
-
Mark
Origin of mutation in sporadic cases of severe haemophilia A in Sweden.
Mårtensson, Annika LU ; Ivarsson, Sten LU ; Letelier, Anna ; Manderstedt, Eric ; Halldén, Christer LU and Ljung, Rolf LU
(2016)
In Clinical Genetics
90(1).
p.63-68
- Contribution to journal › Article
-
Mark
Practical considerations in choosing a factor VIII prophylaxis regimen: Role of clinical phenotype and trough levels.
Ljung, Rolf LU
; Fischer, Kathelijn
; Carcao, Manuel
; Santagostino, Elena
; Manco-Johnson, Marilyn J
and Mathew, Prasad
(2016)
In Thrombosis and Haemostasis
115(5).
p.913-920
- Contribution to journal › Scientific review
- 2015
-
Mark
The current status of prophylactic replacement therapy in children and adults with haemophilia.
- Contribution to journal › Scientific review
-
Mark
Various regimens for prophylactic treatment of patients with haemophilia
Schwarz, Rudolf ; Ljung, Rolf LU
and Tedgård, Ulf
LU
(2015)
In European Journal of Haematology
94.
p.11-16
- Contribution to journal › Scientific review
-
Mark
Can a "center effect" explain the higher frequency of inhibitors for a second generation recombinant factor VIII product?
- Contribution to journal › Letter
-
Mark
Bleeding before prophylaxis in severe hemophilia: paradigm shift over two decades.
Nijdam, Annelies ; Altisent, Carmen ; Carcao, Manuel D ; Cid, Ana R ; Claeyssens-Donadel, Ségolène ; Kurnik, Karin ; Ljung, Rolf LU
; Nolan, Beatrice
; Petrini, Pia
and Platokouki, Helen
, et al.
(2015)
In Haematologica
100(3).
p.84-86
- Contribution to journal › Letter
-
Mark
Switching treatments in haemophilia: is there a risk of inhibitor development?
Santagostino, Elena ; Auerswald, Guenter ; Benson, Gary ; Dolan, Gerry ; Jimenez-Yuste, Victor ; Lambert, Thierry ; Ljung, Rolf LU
; Morfini, Massimo
; Remor, Eduardo
and Salek, Silva Zupancic
(2015)
In European Journal of Haematology
94(4).
p.284-289
- Contribution to journal › Scientific review